Mélissa Bessonne

This study identifies RSV polymerase L as the key mediator of Rab11a interaction, revealing a molecular mechanism for vRNP transport and suggesting therapeutic targets.

The paper identifies artificial proteins (αReps) that inhibit influenza virus replication by targeting FluPol subunits, showing efficacy against multiple virus subtypes.

This paper identifies an intracellular nanobody that inhibits influenza A virus RNA-polymerase by blocking PA-PB1 dimer nuclear import, showing potential for antiviral development.